Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals
WKN: A2H5A0 / Symbol: RYTM / Name: Rhythm Pharmaceuticals / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
81,00 €
-1,22 %
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Morgan Stanley from $150.00 to $136.00. They now have an "overweight" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Royal Bank Of Canada from $140.00 to $130.00. They now have an "outperform" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Citigroup Inc. from $136.00 to $131.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Rhythm Pharmaceuticals (RYTM) had its price target lowered by HC Wainwright from $110.00 to $100.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Rhythm Pharmaceuticals (RYTM) was downgraded by Wall Street Zen from "hold" to "sell".
Ratings data for RYTM provided by MarketBeat
Rhythm Pharmaceuticals (RYTM) had its price target raised by Wells Fargo & Company from $143.00 to $144.00. They now have an "overweight" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Rhythm Pharmaceuticals (RYTM) had its price target raised by Royal Bank Of Canada from $136.00 to $137.00. They now have an "outperform" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Neueste Beiträge
JPMorgan_Chase___Co_ in Solar Capital Ltd diskutieren